Want to stay updated on the latest mining news?

Stay Informed – Subscribe to latest updates. We promise to send only relevant and valuable emails, just insights you care about!

District Reports Voting Results from Its Annual General Meeting of Shareholders

Vancouver, British Columbia–(Newsfile Corp. – December 16, 2025) – District Metals Corp. (TSXV: DMX) (Nasdaq First North: DMXSE SDB) (OTCQX: DMXCF) (FSE: DFPP); (“District” or the “Company“) held its annual general meeting of shareholders on December 10, 2025, in Vancouver, British Columbia (the “Meeting”), and all resolutions were passed. Shareholders voted as follows on […]

LaFleur Minerals Announces LIFE and Flow-Through Unit Offerings

Vancouver, British Columbia–(Newsfile Corp. – December 15, 2025) – LaFleur Minerals Inc. (CSE: LFLR) (FSE: 3WK0) (“LaFleur Minerals” or the “Company” or “Issuer“) is pleased to announce a non-brokered private placement offering of up to 6,000,000 units of the Company (the “Units“) at a price of $0.50 per Unit gross proceeds of up to […]

KO Gold Announces Non-Brokered Private Placement for Gross Proceeds up to C$1,800,000

Toronto, Ontario–(Newsfile Corp. – December 15, 2025) – KO Gold Inc. (CSE: KOG) (“KO Gold” or the “Company“) is pleased to announce a non-brokered private placement (the “Private Placement“) of up to 12,000,000 units (“Units“) at a price of C$0.15 per Unit for gross proceeds of up to C$1,800,000. Each Unit will consist of […]

Probe Gold Announces Filing of Special Meeting Circular and

The board of directors of Probe Gold Inc. unanimously recommends that shareholders vote FOR the proposed plan of arrangement. Your vote is important no matter how many votes you hold. Vote today. Shareholders who have questions or need assistance with voting their shares should contact Probe’s proxy solicitation agent and shareholder communications advisor Laurel Hill […]

Zacks Small Cap Research – EDSA: Gearing Up to Initiate Phase 2 Vitiligo Trial in Mid-2026

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Gearing Up for Phase 2 Vitiligo Trial in Mid-2026 Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of EB06, its anti-CXCL10 monoclonal antibody, for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease that causes areas of […]

Evolve Royalties Ltd. Announces Completion of its Business

Evolve to commence trading on the CSE on December 17, 2025 under the ticker symbol “EVR” Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) — Evolve Royalties Ltd. […]

Zacks Small Cap Research – LGND: 2025 Analyst Day

By John Vandermosten, CFA NASDAQ:LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) held its 2025 analyst day on December 9th, 2025, at the Harvard Club in New York City. The morning presentations highlighted the company’s achievements for 2025 and looked ahead to 2026, providing financial guidance for the next year. Details of […]